Healthy Extracts (HYEX) delays 2025 10-K filing after Gummy USA deal

Rhea-AI Filing Summary

Healthy Extracts Inc. submitted a Form 12b-25 notification that its annual report on Form 10-K for the period ended December 31, 2025 will be filed late. The company states the delay is "as a result of our acquisition of Gummy USA LLC late in the third quarter of 2025" and intends to file the subject Annual Report on Form 10-K on or before the fifteenth calendar day following the prescribed due date.

Key Figures

Period Ended: December 31, 2025 Intended filing window: fifteenth calendar day Notification date: March 31, 2026 +1 more

4 metrics

Period Ended December 31, 2025 Form 10-K reporting period

Intended filing window fifteenth calendar day after the prescribed due date per Form 12b-25 statement

Notification date March 31, 2026 Date the Form 12b-25 was signed

Registrant contact phone (702) 463-1004 Contact for this notification (Kevin “Duke” Pitts)

Key Terms

Form 12b-25, Rule 12b-25(b), Form 10-K

3 terms

Form 12b-25 regulatory

"FORM 12b-25 NOTIFICATION OF LATE FILING"

Form 12b-25 is a notice a publicly traded company files with the U.S. Securities and Exchange Commission when it cannot deliver a required periodic report (like a quarterly or annual financial report) on time. It explains the reason for the delay and gives the company a short, temporary window to finish the report without being marked as delinquent; investors watch it because late filings can signal accounting, operational, or control issues that may affect a company’s reliability and stock risk, much like a missed homework deadline can raise concerns about a student’s preparedness.

Rule 12b-25(b) regulatory

"If the subject report could not be filed without unreasonable effort or expense"

Form 10-K financial

"Check One: <b>[ X ] Form 10-K</b>"

A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.

	UNITED STATES
	SECURITIES AND EXCHANGE COMMISSION	SEC File No: 000-5572
	Washington, D.C. 20549	CUSIP No:  42227D 20 9

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check One):	[ X ] Form 10-K	[  ] Form 20-F	[  ] Form 11-K	[  ] Form 10-Q	[  ] Form 10-D
	[  ] Form N-CEN	[  ] Form N-CSR

For Period Ended: December 31, 2025 

¨		Transition report on Form 10-K
¨		Transition report on Form 20-F
¨		Transition report on Form 11-K
¨		Transition report on Form 10-Q
¨		Transition report on Form N-SAR

For the Transition Period Ended:   

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
_________________________________________________________________________________________

PART 1 -- REGISTRANT INFORMATION

Healthy Extracts Inc.

Full Name of Registrant

Former Name if Applicable

7375 Commercial Way, Suite 125

Address of Principal Executive Office (Street and Number)

Henderson, NV 89011

City, State and Zip Code

PART II -- RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

x		(a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
		(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or a portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
		(c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III -- NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

As a result of our acquisition of Gummy USA LLC late in the third quarter of 2025, data and other information regarding certain material operations of the Company has been unavailable. The Registrant intends to file the subject Annual Report on Form 10-K on or before the fifthteenth calendar day following the prescribed due date.

PART IV-- OTHER INFORMATION

(1)Name and telephone number of person to contact in regard to this notification  

Kevin “Duke” Pitts	(702)	463-1004
(Name)	(Area Code)	(Telephone Number)

(2)Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).   

[ X ]Yes   [ ] No  

(3)Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? 

[ ]Yes   [ X ] No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

Healthy Extracts Inc.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date	March 31, 2026	By	/s/ Kevin “Duke” Pitts
			Kevin “Duke” Pitts
			President